
Rajnish Kumar
About Rajnish Kumar
Data last updated:
Rajnish Kumar has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Dyraa Pharmaceutical India Private Limited and Maxelon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Maxelon Pharmaceuticals Private Limited at ₹30.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Apr 2025 | 2019 | ₹30.2 Lakh (FY 2025) | Active | |
| Director | 04 Sep 2018 | 2018 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajnish Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajnish Kumar
Rajnish Kumar has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Dyraa Pharmaceutical India Private Limited and Maxelon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Maxelon Pharmaceuticals Private Limited at ₹30.2 Lakh (FY 2025).
Rajnish Kumar is associated with 2 companies as Director, including Maxelon Pharmaceuticals Private Limited (₹30.2 Lakh), Dyraa Pharmaceutical India Private Limited.
Rajnish Kumar has expertise in General Business.
Rajnish Kumar has 8 years in corporate governance.
By reported revenue, the largest current company of Rajnish Kumar is Maxelon Pharmaceuticals Private Limited, with revenue of ₹30.2 Lakh (FY 2025).
Rajnish Kumar currently holds positions at 2 companies: Maxelon Pharmaceuticals Private Limited (₹30.2 Lakh), Dyraa Pharmaceutical India Private Limited.